BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $135,710 | -24.3% | 5,594 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $179,288 | +6.0% | 5,594 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $169,107 | -10.2% | 5,594 | +25.2% | 0.00% | 0.0% |
Q2 2020 | $188,329 | +69.0% | 4,467 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $111,452 | – | 4,467 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |